Oramed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ORMP Oramed Pharmaceuticals Inc
GOTU Gaotu Techedu Inc
SGDVV Safe & Green Development Corp
GLBZ Glen Burnie Bancorp
PHAR Pharming Group NV
CARD Max Auto Industry -3X Inverse Leveraged ETN
HIW Highwoods Properties Inc
HFRO Highland Opportunities and Income Fund
HDV iShares Core High Dividend ETF
HDELY Heidelberg Materials AG

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Oramed Pharmaceuticals Inc. is a pharmaceutical company, which is engaged in the research and development of pharmaceutical solutions with its technology platform. Its POD (Protein Oral Delivery) technology has been designed to protect orally delivered proteins from detrimental enzymatic activity within the gastrointestinal tract and to enhance their absorption across the intestinal wall. Its pipeline includes ORMD-0801 diabetes, ORMD-0901, and ORMD-0801 non-alcoholic steatohepatitis (NASH). Its flagship product, ORMD-0801, allows insulin to travel from the gastrointestinal tract via the portal vein to the liver. It is conducting Phase III trials in patients with type 2 diabetes. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone, that stimulates the secretion of insulin from the pancreas. It is also engaged in the research and development of an oral vaccine for COVID-19 through its subsidiary, Oravax Medical Inc.


Last Trade
0.10 (3.80%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

Bank branch closings slow in April to below 12-month trailing average: S&P

12:20 pm ET May 30, 2023 (MarketWatch)

By Steve Gelsi

PNC closed 21 branches as the most active reducer in April, but banks overall shut down fewer branches than they did in March

U.S. banks closed fewer branches in April than March, S&P Global Market Intelligence said Tuesday.

All told, U.S. banks closed 130 branches and opened 51 in April for a net reduction of 79, down from 100 in March. The 79 figure is also below the trailing 12-month average of 114.

U.S. banks operated 78,475 active branches as of April 30, according to S&P.

PNC Financial Services Group Inc. (PNC) closed 21 branches in April, the most of any U.S. bank. The bank did not immediately reply to a request for comment.

Meanwhile, Banco Santander (SAN.MC) closed 12 branches in April and U.S. Bancorp (USB) closed nine.

Also read: These are the leading candidates to succeed James Gorman as Morgan Stanley CEO -- and what happens next

JPMorgan Chase & Co. (JPM) opened a net seven bank branches, the most of any U.S. bank in April.

The bank opened a total of 114 branches in 2022. It was the first retail bank with branches in all of the lower 48 U.S. states. It has also added more than 650 branches since 2018, according to an investor presentation.

JPMorgan has also consolidated branches at a rate comparable to that of other large banks, according to the presentation.

Also read:Ex-CEO of Silicon Valley Bank not off the hook for stock sales ahead of bank collapse, law professor says

-Steve Gelsi

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

May 30, 2023 12:20 ET (16:20 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.